Disclosure Of Interests In Other Entities [Text Block]

Innate Pharma - Filing #2821023

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	As at 2018-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	173 451 EUR	—	—	—	—	—	237 605 EUR	—
Non-current assets	—	—	133 972 EUR	—	—	—	—	—	163 756 EUR	—
Current liabilities	—	—	45 488 EUR	—	—	—	—	—	121 822 EUR	—
Non-current liabilities	—	—	105 959 EUR	—	—	—	—	—	62 123 EUR	—
Revenue	—	—	—	70 451 EUR	—	—	—	85 814 EUR	—	—
Profit (loss)	—	—	—	63 984 EUR	63 984 EUR	—	20 759 EUR	20 759 EUR	—	—
Comprehensive income	805,000 EUR	827,000 EUR	—	63 962 EUR	63 984 EUR	627,000 EUR	20 759 EUR	20 132 EUR	—	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	—	22,000 EUR	—	—	—	627,000 EUR	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	136 792 EUR	—	—	—	—	—	202 887 EUR	152 314 EUR
Tax expense (income)	—	—	—	— EUR	—	—	—	— EUR	—	—